Clinical trials: Prefrail

Inflammatory Response

Effects of Metformin in a Non-Diabetic Patient Population

• Completed
• Age: 55 to 85 years
• Phase 1/2
• Results posted

Metformin has a well-established safety profile and it has become clear that metformin has additional salutary effects, including anti-inflammatory, anti-aging, and anti-thrombotic properties.

Trial name

NCT03772964

Testing

MetFORMIN Hydrochloride ER

Where

United States

Volunteers

32 people, healthy volunteers welcome

Sponsor

Brian Zuckerbraun